Biographical Sketch
W.H. Wilson Tang, MD, is Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Tang’s specialty interests include cardiomyopathy, heart failure, heart transplantation, diabetic heart diseases and cancer-related heart diseases. He is currently Research Director of the Section of Heart Failure and Cardiac Transplantation Medicine in the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic, and has joint appointments with the Department of Cell Biology and the Genomic Medicine Institute at Cleveland Clinic's Lerner Research Institute.
Dr. Tang graduated magna cum laude with a Bachelor of Science degree from Brown University in Rhode Island, where he received an honorary one-year period of study of the natural sciences at Jesus College, Cambridge University, in England. Dr. Tang received his medical degree from Harvard Medical School.
Dr. Tang completed his internship and residency in internal medicine and a research fellowship in heart failure at Stanford University Medical Center. This was followed by a Cleveland Clinic fellowship in clinical cardiology, and an advanced clinical fellowship in heart failure and cardiac transplantation. He was appointed to Cleveland Clinic in 2004 as a Staff Physician in the Section of Heart Failure and Cardiac Transplantation Medicine. He is board-certified in internal medicine and cardiovascular medicine.
Dr. Tang is an author or co-author of over 130 published peer-reviewed articles in medical and scientific journals as well as chapters in medical textbooks. He has also been invited to speak on his specialty interests at regional, national and international conferences, particularly on the subject of cardiomyopathy, heart failure, biomarkers and diabetic heart diseases. He is an Associate Editor for Journal of Cardiac Failure, and is on the International Advisory Editorial Board for Heart.
Dr. Tang’s current research interests include neurohormonal and metabolic mechanisms in the pathophysiology of heart failure, diagnosis and management of co-morbidities in patients with heart failure and the use of biomarkers, cardio-renal interactions, and device-based monitoring in heart failure. He is a member of the steering committee for several national and international drug and device clinical trials.
Dr. Tang is a Fellow of the American College of Cardiology and a Fellow of the American Heart Association. He has active leadership roles in the Heart Failure Society of America and the American College of Cardiology, and is a member of the American College of Physicians, International Society of Heart and Lung Transplantation and the American Diabetes Association.
Specialty Interests
cardiomyopathy, heart failure, cardiac transplantation and mechanical circulatory support, cardiac resynchronization, diabetic and cancer-related heart disease, cardio-renal syndrome
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 9/8/2008,
Dr. Tang has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
